Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 438680, 10 pages
http://dx.doi.org/10.1155/2013/438680
Research Article

Metabolomics Study of Resina Draconis on Myocardial Ischemia Rats Using Ultraperformance Liquid Chromatography/Quadrupole Time-of-Flight Mass Spectrometry Combined with Pattern Recognition Methods and Metabolic Pathway Analysis

Yunpeng Qi,1,2,3 Haiwei Gu,4,5 Yunlong Song,1,2,3 Xin Dong,1,2,3 Aijun Liu,6 Ziyang Lou,1,2,3 Guorong Fan,1,2,3 and Yifeng Chai1,2,3

1Department of Pharmaceutical Analysis, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China
2Shanghai Key Laboratory for Pharmaceutical Metabolite Research, 325 Guohe Road, Shanghai 200433, China
3Shanghai Research Centre for Drug (Chinese Materia Medica) Metabolism, 325 Guohe Road, Shanghai 200433, China
4Jiangxi Key Laboratory for Mass Spectrometry and Instrumentation, East China Institute of Technology, Nanchang, Jiangxi 330013, China
5Department of Anesthesiology & Pain Medicine, University of Washington, Seattle, WA 98195, USA
6Department of Pharmacology, School of Pharmacy, Second Military Medical University, 325 Guohe Road, Shanghai 200433, China

Received 7 February 2013; Revised 24 April 2013; Accepted 24 April 2013

Academic Editor: Roja Rahimi

Copyright © 2013 Yunpeng Qi et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Shimokawa and S. Yasuda, “Myocardial ischemia: current concepts and future perspectives,” Journal of Cardiology, vol. 52, no. 2, pp. 67–78, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Karmazyn, Myocardial Ischemia: Mechanisms, Reperfusion, Protection, Birkhäuser, Basel, Switzerland, 1996.
  3. R. A. P. Weir and J. J. V. McMurray, “Epidemiology of heart failure and left ventricular dysfunction after acute myocardial infarction,” Current Heart Failure Reports, vol. 3, no. 4, pp. 175–180, 2006. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Torabi, J. G. F. Cleland, N. K. Khan et al., “The timing of development and subsequent clinical course of heart failure after a myocardial infarction,” European Heart Journal, vol. 29, no. 7, pp. 859–870, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. D. Gupta, B. Bleakley, and R. K. Gupta, “Dragon's blood: botany, chemistry and therapeutic uses,” Journal of Ethnopharmacology, vol. 115, no. 3, pp. 361–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Xin, Y. J. Li, Y. Li et al., “Dragon's Blood extract has antithrombotic properties, affecting platelet aggregation functions and anticoagulation activities,” Journal of Ethnopharmacology, vol. 135, no. 2, pp. 510–514, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. J. J. Ma, Y. Song, M. Jia, and C. L. Li, “Effect of total flavone in Sanguis draconis on platelet aggregation, thrombus formation and myocardial ischemia,” Chinese Traditional and Herbal Drugs, vol. 33, pp. 1008–1010, 2002. View at Google Scholar
  8. W. R. Fang, Y. M. Li, and J. Y. Deng, “Protective effect of sanguis draxonis flavones on animal myocardial ischemia,” Chinese Journal of Clinical Pharmacology and Therapeutics, vol. 10, pp. 1020–1024, 2005. View at Google Scholar
  9. J. K. Nicholson, J. C. Lindon, and E. Holmes, “‘Metabonomics’: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data,” Xenobiotica, vol. 29, no. 11, pp. 1181–1189, 1999. View at Google Scholar · View at Scopus
  10. J. K. Nicholson, J. Connelly, J. C. Lindon, and E. Holmes, “Metabonomics: a platform for studying drug toxicity and gene function,” Nature Reviews Drug Discovery, vol. 1, no. 2, pp. 153–161, 2002. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Orešič, A. Vidal-Puig, and V. Hänninen, “Metabolomic approaches to phenotype characterization and applications to complex diseases,” Expert Review of Molecular Diagnostics, vol. 6, no. 4, pp. 575–585, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. G. A. N. Gowda, S. Zhang, H. Gu, V. Asiago, N. Shanaiah, and D. Raftery, “Metabolomics-based methods for early disease diagnostics,” Expert Review of Molecular Diagnostics, vol. 8, no. 5, pp. 617–633, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. S. L. Robinette, R. Bruschweiler, F. C. Schroeder, and A. S. Edison, “NMR in metabolomics and natural products research: two sides of the same coin,” Accounts of Chemical Research, vol. 45, no. 2, pp. 288–297, 2012. View at Publisher · View at Google Scholar
  14. G. Paglia, S. Hrafnsdottir, M. Magnusdottir et al., “Monitoring metabolites consumption and secretion in cultured cells using ultra-performance liquid chromatography quadrupole-time of flight mass spectrometry (UPLC-Q-ToF-MS),” Analytical and Bioanalytical Chemistry, vol. 402, no. 3, pp. 1183–1198, 2012. View at Publisher · View at Google Scholar
  15. A. Scalbert, L. Brennan, O. Fiehn et al., “Mass-spectrometry-based metabolomics: limitations and recommendations for future progress with particular focus on nutrition research,” Metabolomics, vol. 5, no. 4, pp. 435–458, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. L. H. Jorgensen, E. Thaulow, and H. E. Refsum, “Early hemodynamic effects at rest with acute and chronic isosorbide dinitrate treatment in patients with ischemic heart disease,” Clinical Cardiology, vol. 18, no. 8, pp. 455–459, 1995. View at Publisher · View at Google Scholar
  17. P. Jerie, “Milestones of cardiovascular therapy. III. Nitroglycerin,” Casopis Lékaru Ceských, vol. 146, no. 6, pp. 533–537, 2007. View at Google Scholar
  18. K. Ytrehus, “Models of myocardial ischemia,” Drug Discovery Today: Disease Models, vol. 3, no. 3, pp. 263–271, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Trygg, E. Holmes, and T. Lundstedt, “Chemometrics in metabonomics,” Journal of Proteome Research, vol. 6, no. 2, pp. 469–479, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. M. Chagoyen and F. Pazos, “MBRole: enrichment analysis of metabolomic data,” Bioinformatics, vol. 27, no. 5, Article ID btr001, pp. 730–731, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Y. Zheng, J. Sun, X. Zhao, and J. G. Xu, “Protective effect of Shen-Fu on myocardial ischemia-reperfusion injury in rats,” The American Journal of Chinese Medicine, vol. 32, no. 2, pp. 209–220, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. T. Todorovski, M. Fedorova, and R. Hoffmann, “Mass spectrometric characterization of peptides containing different oxidized tryptophan residues,” Journal of Mass Spectrometry, vol. 46, no. 10, pp. 1030–1038, 2011. View at Publisher · View at Google Scholar
  23. D. N. Anderson, A. M. Wilkinson, M. T. Abou-Saleh, and J. A. Blair, “Recovery from depression after electroconvulsive therapy is accompanied by evidence of increased tetrahydrobiopterin-dependent hydroxylation,” Acta Psychiatrica Scandinavica, vol. 90, no. 1, pp. 10–13, 1994. View at Google Scholar · View at Scopus
  24. D. Rosenblatt and C. R. Scriver, “Heterogeneity in genetic control of phenylalanine metabolism in man,” Nature, vol. 218, no. 5142, pp. 677–678, 1968. View at Publisher · View at Google Scholar · View at Scopus
  25. P. Jiang, W. Dai, S. Yan et al., “Potential biomarkers in the urine of myocardial infarction rats: a metabolomic method and its application,” Molecular BioSystems, vol. 7, no. 3, pp. 824–831, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. Tan, Z. Lou, W. Liao et al., “Hydrophilic interaction and reversed-phase ultraperformance liquid chromatography TOF-MS for serum metabonomic analysis of myocardial infarction in rats and its applications,” Molecular BioSystems, vol. 8, no. 2, pp. 548–556, 2012. View at Publisher · View at Google Scholar
  27. M. Morgado, E. Cairrao, A. J. Santos-Silva, and I. Verde, “Cyclic nucleotide-dependent relaxation pathways in vascular smooth muscle,” Cellular and Molecular Life Sciences, vol. 69, no. 2, pp. 247–266, 2012. View at Publisher · View at Google Scholar
  28. N. Sperelakis, “Regulation of calcium slow channels of heart by cyclic nucleotides and effects of ischemia,” Advances in Pharmacology, vol. 31, pp. 1–24, 1994. View at Publisher · View at Google Scholar · View at Scopus
  29. N. V. Naryzhnaya, L. N. Maslov, Y. B. Lishmanov, and F. Kolář, “Effect of stress adaptation on cyclic nucleotide content in myocardial tissue during acute ischemia/reperfusion,” Bulletin of Experimental Biology and Medicine, vol. 145, no. 5, pp. 588–591, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. E. F. du Toit and L. H. Opie, “Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion,” Circulation Research, vol. 70, no. 5, pp. 960–967, 1992. View at Google Scholar · View at Scopus
  31. Y. T. Xuan, X. L. Tang, Y. Qiu et al., “Biphasic response of cardiac NO synthase isoforms to ischemic preconditioning in conscious rabbits,” The American Journal of Physiology, vol. 279, no. 5, pp. H2360–H2371, 2000. View at Google Scholar · View at Scopus
  32. H. C. Hartzell and R. Fischmeister, “Opposite effects of cyclic GMP and cyclic AMP on Ca2+ current in single heart cells,” Nature, vol. 323, no. 6085, pp. 273–275, 1986. View at Google Scholar · View at Scopus
  33. K. Sumii and N. Sperelakis, “cGMP-dependent protein kinase regulation of the L-type Ca2+ current in rat ventricular myocytes,” Circulation Research, vol. 77, no. 4, pp. 803–812, 1995. View at Google Scholar · View at Scopus
  34. K. C. Madison, D. C. Swartzendruber, P. W. Wertz, and D. T. Downing, “Sphingolipid metabolism in organotypic mouse keratinocyte cultures,” Journal of Investigative Dermatology, vol. 95, no. 6, pp. 657–664, 1990. View at Google Scholar · View at Scopus
  35. S. Gundewar and D. J. Lefer, “Sphingolipid therapy in myocardial ischemia-reperfusion injury,” Biochimica et Biophysica Acta, vol. 1780, no. 3, pp. 571–576, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. P. C. Choy, M. Chan, G. Hatch, and R. Y. K. Man, “Phosphatidylcholine metabolism in ischemic and hypoxic hearts,” Molecular and Cellular Biochemistry, vol. 116, no. 1-2, pp. 53–58, 1992. View at Publisher · View at Google Scholar · View at Scopus
  37. S. M. Lohmann, R. Fischmeister, and U. Walter, “Signal transduction by cGMP in heart,” Basic Research in Cardiology, vol. 86, no. 6, pp. 503–514, 1991. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Pavoine and F. Pecker, “Sphingomyelinases: their regulation and roles in cardiovascular pathophysiology,” Cardiovascular Research, vol. 82, no. 2, pp. 175–183, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. P. H. McNulty, R. Jacob, L. I. Deckelbaum, and L. H. Young, “Effect of hyperinsulinemia on myocardial amino acid uptake in patients with coronary artery disease,” Metabolism: Clinical and Experimental, vol. 49, no. 10, pp. 1365–1369, 2000. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Virmani and Z. Binienda, “Role of carnitine esters in brain neuropathology,” Molecular Aspects of Medicine, vol. 25, no. 5-6, pp. 533–549, 2004. View at Publisher · View at Google Scholar · View at Scopus